BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baindara P, Korpole S, Grover V. Bacteriocins: perspective for the development of novel anticancer drugs. Appl Microbiol Biotechnol 2018;102:10393-408. [PMID: 30338356 DOI: 10.1007/s00253-018-9420-8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Ghanavati R, Akbari A, Mohammadi F, Asadollahi P, Javadi A, Talebi M, Rohani M. Lactobacillus species inhibitory effect on colorectal cancer progression through modulating the Wnt/β-catenin signaling pathway. Mol Cell Biochem 2020;470:1-13. [PMID: 32419125 DOI: 10.1007/s11010-020-03740-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Radaic A, de Jesus MB, Kapila YL. Bacterial anti-microbial peptides and nano-sized drug delivery systems: The state of the art toward improved bacteriocins. J Control Release 2020;321:100-18. [PMID: 32035192 DOI: 10.1016/j.jconrel.2020.02.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
3 Baindara P, Mandal SM. Antimicrobial Peptides and Vaccine Development to Control Multi-drug Resistant Bacteria. Protein Pept Lett 2019;26:324-31. [PMID: 31237198 DOI: 10.2174/0929866526666190228162751] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
4 Ebrahimzadeh S, Ahangari H, Soleimanian A, Hosseini K, Ebrahimi V, Ghasemnejad T, Soofiyani SR, Tarhriz V, Eyvazi S. Colorectal cancer treatment using bacteria: focus on molecular mechanisms. BMC Microbiol 2021;21:218. [PMID: 34281519 DOI: 10.1186/s12866-021-02274-3] [Reference Citation Analysis]
5 Wang T, Fu J, Xiao X, Lu Z, Wang F, Jin M, Wang Y, Zong X. CBP22, a Novel Bacteriocin Isolated from Clostridium butyricum ZJU-F1, Protects against LPS-Induced Intestinal Injury through Maintaining the Tight Junction Complex. Mediators Inflamm 2021;2021:8032125. [PMID: 34158805 DOI: 10.1155/2021/8032125] [Reference Citation Analysis]
6 Navarro SA, Lanza L, Acuña L, Bellomio A, Chalón MC. Features and applications of Ent35-MccV hybrid bacteriocin: current state and perspectives. Appl Microbiol Biotechnol 2020;104:6067-77. [PMID: 32418126 DOI: 10.1007/s00253-020-10650-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Kohoutova D, Forstlova M, Moravkova P, Cyrany J, Bosak J, Smajs D, Rejchrt S, Bures J. Bacteriocin production by mucosal bacteria in current and previous colorectal neoplasia. BMC Cancer 2020;20:39. [PMID: 31948419 DOI: 10.1186/s12885-020-6512-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Dong N, Wang C, Zhang T, Zhang L, Xue C, Feng X, Bi C, Shan A. Bioactivity and Bactericidal Mechanism of Histidine-Rich β-Hairpin Peptide Against Gram-Negative Bacteria. Int J Mol Sci 2019;20:E3954. [PMID: 31416220 DOI: 10.3390/ijms20163954] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
9 Baindara P, Ghosh AK, Mandal SM. Coevolution of Resistance Against Antimicrobial Peptides. Microb Drug Resist 2020;26:880-99. [PMID: 32119634 DOI: 10.1089/mdr.2019.0291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Sawant SS, Patil SM, Gupta V, Kunda NK. Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment. Int J Mol Sci 2020;21:E7575. [PMID: 33066447 DOI: 10.3390/ijms21207575] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
11 Nguyen VD, Nguyen TT, Pham TT, Packianather M, Le CH. Molecular screening and genetic diversity analysis of anticancer Azurin-encoding and Azurin-like genes in human gut microbiome deduced through cultivation-dependent and cultivation-independent studies. Int Microbiol 2019;22:437-49. [PMID: 30895406 DOI: 10.1007/s10123-019-00070-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Stott KJ, Phillips B, Parry L, May S. Recent advancements in the exploitation of the gut microbiome in the diagnosis and treatment of colorectal cancer. Biosci Rep 2021:BSR20204113. [PMID: 34236075 DOI: 10.1042/BSR20204113] [Reference Citation Analysis]
13 Tymoszewska A, Walczak P, Aleksandrzak-piekarczyk T. BacSJ—Another Bacteriocin with Distinct Spectrum of Activity that Targets Man-PTS. IJMS 2020;21:7860. [DOI: 10.3390/ijms21217860] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
14 Meade E, Slattery MA, Garvey M. Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile? Antibiotics (Basel) 2020;9:E32. [PMID: 31963311 DOI: 10.3390/antibiotics9010032] [Cited by in Crossref: 67] [Cited by in F6Publishing: 49] [Article Influence: 33.5] [Reference Citation Analysis]
15 Feng JP, Zhu R, Jiang F, Xie J, Gao C, Li M, Jin H, Fu D. Melittin-encapsulating peptide hydrogels for enhanced delivery of impermeable anticancer peptides. Biomater Sci 2020;8:4559-69. [PMID: 32672773 DOI: 10.1039/c9bm02080b] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Laliani G, Ghasemian Sorboni S, Lari R, Yaghoubi A, Soleimanpour S, Khazaei M, Hasanian SM, Avan A. Bacteria and cancer: Different sides of the same coin. Life Sci 2020;246:117398. [PMID: 32032647 DOI: 10.1016/j.lfs.2020.117398] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
17 Collin F, Maxwell A. The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents. J Mol Biol 2019;431:3400-26. [PMID: 31181289 DOI: 10.1016/j.jmb.2019.05.050] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
18 Sulthana R, Archer AC. Bacteriocin nanoconjugates: boon to medical and food industry. J Appl Microbiol 2021;131:1056-71. [PMID: 33368869 DOI: 10.1111/jam.14982] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Atashzar MR, Hamblin MR, Maleki F, Kouhsari E. Tumor cryotherapy using Ice-producing bacteria. Med Hypotheses 2020;144:110101. [PMID: 32758898 DOI: 10.1016/j.mehy.2020.110101] [Reference Citation Analysis]
20 Mueller A, Brockmueller A, Fahimi N, Ghotbi T, Hashemi S, Sadri S, Khorshidi N, Kunnumakkara AB, Shakibaei M. Bacteria-Mediated Modulatory Strategies for Colorectal Cancer Treatment. Biomedicines 2022;10:832. [DOI: 10.3390/biomedicines10040832] [Reference Citation Analysis]
21 Rodrigues G, Silva GGO, Buccini DF, Duque HM, Dias SC, Franco OL. Bacterial Proteinaceous Compounds With Multiple Activities Toward Cancers and Microbial Infection. Front Microbiol 2019;10:1690. [PMID: 31447795 DOI: 10.3389/fmicb.2019.01690] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
22 Raheem A, Wang M, Zhang J, Liang L, Liang R, Yin Y, Zhu Y, Yang W, Wang L, Lv X, Jia Y, Qin T, Zhang G. The probiotic potential of Lactobacillus plantarum strain RW1 isolated from canine faeces. J Appl Microbiol 2021. [PMID: 34709709 DOI: 10.1111/jam.15341] [Reference Citation Analysis]
23 Yousefy Z, Esmaeili D, Goudarzi H. Cloning and the expression of the protein fusion enterocin-nisin-epidermicin T as a candidate for the treatment of gastric cancer. Gene Reports 2021;24:101088. [DOI: 10.1016/j.genrep.2021.101088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sharma S, Barman P, Joshi S, Preet S, Saini A. Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics. Colloids Surf B Biointerfaces 2021;211:112303. [PMID: 34952285 DOI: 10.1016/j.colsurfb.2021.112303] [Reference Citation Analysis]
25 Aghamiri S, Zandsalimi F, Raee P, Abdollahifar MA, Tan SC, Low TY, Najafi S, Ashrafizadeh M, Zarrabi A, Ghanbarian H, Bandehpour M. Antimicrobial peptides as potential therapeutics for breast cancer. Pharmacol Res 2021;171:105777. [PMID: 34298112 DOI: 10.1016/j.phrs.2021.105777] [Reference Citation Analysis]
26 Costa-Trigo I, Paz A, Otero-Penedo P, Outeiriño D, Pérez Guerra N, Domínguez JM. Enhancing the saccharification of pretreated chestnut burrs to produce bacteriocins. J Biotechnol 2021;329:13-20. [PMID: 33476740 DOI: 10.1016/j.jbiotec.2021.01.010] [Reference Citation Analysis]
27 González-Pérez CJ, Aispuro-Hernández E, Vargas-Arispuro I, Hernández-Mendoza A, Ayala Zavala JF, Martínez-Téllez MA. Are Bacteriocins a Feasible Solution for Current Diverse Global Problems? Protein Pept Lett 2021. [PMID: 34629038 DOI: 10.2174/0929866528666211008154430] [Reference Citation Analysis]
28 Goh KS, Ng ZJ, Halim M, Oslan SN, Oslan SNH, Tan JS. A Comprehensive Review on the Anticancer Potential of Bacteriocin: Preclinical and Clinical Studies. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10386-1] [Reference Citation Analysis]
29 Zgheib H, Drider D, Belguesmia Y. Broadening and Enhancing Bacteriocins Activities by Association with Bioactive Substances. Int J Environ Res Public Health 2020;17:E7835. [PMID: 33114656 DOI: 10.3390/ijerph17217835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Hussain MS, Vashist A, Kumar M, Taneja NK, Gautam US, Dwivedi S, Tyagi JS, Gupta RK. Anti-mycobacterial activity of heat and pH stable high molecular weight protein(s) secreted by a bacterial laboratory contaminant. Microb Cell Fact 2022;21. [DOI: 10.1186/s12934-022-01743-2] [Reference Citation Analysis]
31 Xu Z, Yang Q, Zhu Y. Transcriptome analysis reveals the molecular mechanisms of the novel Lactobacillus pentosus pentocin against Bacillus cereus. Food Res Int 2022;151:110840. [PMID: 34980379 DOI: 10.1016/j.foodres.2021.110840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Raheem A, Liang L, Zhang G, Cui S. Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis on Immune Regulation. Front Immunol 2021;12:616713. [PMID: 33897683 DOI: 10.3389/fimmu.2021.616713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Varas MA, Muñoz-Montecinos C, Kallens V, Simon V, Allende ML, Marcoleta AE, Lagos R. Exploiting Zebrafish Xenografts for Testing the in vivo Antitumorigenic Activity of Microcin E492 Against Human Colorectal Cancer Cells. Front Microbiol 2020;11:405. [PMID: 32265865 DOI: 10.3389/fmicb.2020.00405] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
34 Baindara P, Nallabelli N, Korpole S. Whole genome mining reveals a diverse repertoire of lanthionine synthetases and lanthipeptides among the genus Paenibacillus. J Appl Microbiol 2020;128:473-90. [DOI: 10.1111/jam.14495] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Zhang G, Raheem A, Gao X, Zhang J, Shi L, Wang M, Li M, Yin Y, Li S, Cui X, Yan X, Yue M, Wen H, Qin T. Cytoprotective Effects of Lactobacilli on Mouse Epithelial Cells during Salmonella Infection. Fermentation 2022;8:101. [DOI: 10.3390/fermentation8030101] [Reference Citation Analysis]
36 Kamarajan P, Ateia I, Shin JM, Fenno JC, Le C, Zhan L, Chang A, Darveau R, Kapila YL. Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocin. PLoS Pathog 2020;16:e1008881. [PMID: 33002094 DOI: 10.1371/journal.ppat.1008881] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
37 Daba GM, Elkhateeb WA. Bacteriocins of lactic acid bacteria as biotechnological tools in food and pharmaceuticals: Current applications and future prospects. Biocatalysis and Agricultural Biotechnology 2020;28:101750. [DOI: 10.1016/j.bcab.2020.101750] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
38 Naskar A, Kim KS. Potential Novel Food-Related and Biomedical Applications of Nanomaterials Combined with Bacteriocins. Pharmaceutics 2021;13:86. [PMID: 33440722 DOI: 10.3390/pharmaceutics13010086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Singh K, Gera R, Sharma R, Maithani D, Chandra D, Bhat MA, Kumar R, Bhatt P. Mechanism and application of Sesbania root-nodulating bacteria: an alternative for chemical fertilizers and sustainable development. Arch Microbiol 2021;203:1259-70. [PMID: 33388789 DOI: 10.1007/s00203-020-02137-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Anjana, Tiwari SK. Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota. Front Cell Infect Microbiol 2022;12:851140. [DOI: 10.3389/fcimb.2022.851140] [Reference Citation Analysis]
41 Zhang C, Yang M, Ericsson AC. Antimicrobial Peptides: Potential Application in Liver Cancer. Front Microbiol. 2019;10:1257. [PMID: 31231341 DOI: 10.3389/fmicb.2019.01257] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
42 Gong Z, Liu X, Zhou B, Wang G, Guan X, Xu Y, Zhang J, Hong Z, Cao J, Sun X, Gao Z, Lu H, Pan X, Bai J. Tumor acidic microenvironment-induced drug release of RGD peptide nanoparticles for cellular uptake and cancer therapy. Colloids Surf B Biointerfaces 2021;202:111673. [PMID: 33714186 DOI: 10.1016/j.colsurfb.2021.111673] [Reference Citation Analysis]
43 Li C, Alam K, Zhao Y, Hao J, Yang Q, Zhang Y, Li R, Li A. Mining and Biosynthesis of Bioactive Lanthipeptides From Microorganisms. Front Bioeng Biotechnol 2021;9:692466. [PMID: 34395400 DOI: 10.3389/fbioe.2021.692466] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Baindara P, Mandal SM. Bacteria and bacterial anticancer agents as a promising alternative for cancer therapeutics. Biochimie 2020;177:164-89. [PMID: 32827604 DOI: 10.1016/j.biochi.2020.07.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
45 Cesa-Luna C, Alatorre-Cruz JM, Carreño-López R, Quintero-Hernández V, Baez A. Emerging Applications of Bacteriocins as Antimicrobials, Anticancer Drugs, and Modulators of The Gastrointestinal Microbiota. Pol J Microbiol 2021;70:143-59. [PMID: 34349808 DOI: 10.33073/pjm-2021-020] [Reference Citation Analysis]